SB-206553

SB-206553 is a compound that is often used in scientific research. It acts as an antagonist at the 5-HT2B receptor and the 5-HT2C receptor, and has been shown to suppress the action of MDMA. It is also a potent and selective antagonist of the P2X purinergic receptor.

Pharmacology

SB-206553 has been found to act as a potent and selective antagonist of the P2X purinergic receptor, which is involved in various physiological processes, including neurotransmission, inflammation, and platelet aggregation. It has also been shown to act as an antagonist at the 5-HT2B and 5-HT2C receptors, which are involved in the regulation of mood, appetite, and sleep.

Research

Research has shown that SB-206553 can suppress the action of MDMA, a psychoactive drug that is commonly used recreationally. This suggests that the compound may have potential therapeutic applications in the treatment of MDMA abuse.

See also

• 5-HT2B receptor
• 5-HT2C receptor
• P2X purinergic receptor
• MDMA

References

SB-206553 Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski